Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy).
Serebruany VL, Malinin AI, O'connor CM, Gurbel PA; Roxifiban Oral Compound Kinetics Evaluation Trial-I Platelet Substudy. Serebruany VL, et al. Am Heart J. 2003 Jul;146(1):91-8. doi: 10.1016/S0002-8703(03)00186-8. Am Heart J. 2003. PMID: 12851613 Clinical Trial.
Failure of platelet parameters and biomarkers to correlate platelet function to severity and etiology of heart failure in patients enrolled in the EPCOT trial. With special reference to the Hemodyne hemostatic analyzer. Whole Blood Impedance Aggregometry for the Assessment of Platelet Function in Patients with Congestive Heart Failure.
Serebruany VL, McKenzie ME, Meister AF, Fuzaylov SY, Gurbel PA, Atar D, Gattis WA, O'Connor CM. Serebruany VL, et al. Pathophysiol Haemost Thromb. 2002 Jan-Feb;32(1):8-15. doi: 10.1159/000057283. Pathophysiol Haemost Thromb. 2002. PMID: 12214158 Clinical Trial.
1,137 results